209 related articles for article (PubMed ID: 6023602)
1. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
Moore KE; Rech RH
J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
[No Abstract] [Full Text] [Related]
2. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
Rech RH; Borys HK; Moore KE
J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
[No Abstract] [Full Text] [Related]
3. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
Rech RH; Carr LA; Moore KE
J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
[No Abstract] [Full Text] [Related]
4. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
Dominic JA; Moore KE
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
[No Abstract] [Full Text] [Related]
5. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
Weissman A; Koe BK; Tenen SS
J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
[No Abstract] [Full Text] [Related]
6. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
Moore KE; Rech RH
J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
[No Abstract] [Full Text] [Related]
7. Affective disorders and norepinephrine pharmacology.
Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
[No Abstract] [Full Text] [Related]
8. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
Kitaichi Y
Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
[No Abstract] [Full Text] [Related]
9. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
Davis WM; Babbini M; Khalsa HJ
Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
[No Abstract] [Full Text] [Related]
10. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
11. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
Pfeifer AK; Galambos E
Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
[No Abstract] [Full Text] [Related]
12. The influence of monoamine oxidase inhibition on catecholamine synthesis.
Neff NH; Costa E
Life Sci; 1966 May; 5(10):951-9. PubMed ID: 5961718
[No Abstract] [Full Text] [Related]
13. Effect of carbaryl on catecholamines in brain regions.
Ray SK; Haque SJ; Poddar MK
Indian J Exp Biol; 1984 Mar; 22(3):141-4. PubMed ID: 6440860
[No Abstract] [Full Text] [Related]
14. Studies on the functional role of intraneuronal monamine oxidase.
Clarke DE; Sampath SS
J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
[No Abstract] [Full Text] [Related]
15. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
Neff NH; Costa E
J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
[No Abstract] [Full Text] [Related]
16. Relationship of brain dopamine to stress-induced changes in seizure susceptibility.
Goldberg ME; Salama AI
Eur J Pharmacol; 1970; 10(3):333-8. PubMed ID: 5422459
[No Abstract] [Full Text] [Related]
17. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
Corrodi H; Fuxe K
Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
[No Abstract] [Full Text] [Related]
18. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
Scheel-Krüger J
Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
[No Abstract] [Full Text] [Related]
19. The effect of ethanol on the activity of central catecholamine neurones in rat brain.
Corrodi H; Fuxe K; Hökfelt T
J Pharm Pharmacol; 1966 Dec; 18(12):821-3. PubMed ID: 4381667
[No Abstract] [Full Text] [Related]
20. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
